BTAIVSCON• 12 Months (Normalized)
BTAI vs CON (BioXcel Therapeutics Inc. vs Concentra Group Holdings Parent Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
CON Performance $35.65
+72.31%
Concentra Group Holdings Parent Inc.
Normalized Baseline0.00%
Alpha Spread Margin CON LEADS
-72.31 pts
CON outperforming by 72.31 percentage points
BTAICON
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI CON
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BTAI Price | BTAI Gain (%) | CON Price | CON Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $- | $35.65 | +72.31% | - | |
| Sep 30, 2026 | $- | $35.08 | +69.55% | - | |
| Sep 29, 2026 | $- | $35.34 | +70.81% | - | |
| Sep 28, 2026 | $- | $35.36 | +70.90% | - | |
| Sep 25, 2026 | $- | $35.01 | +69.21% | - | |
| Sep 24, 2026 | $0.04 | -98.66% | $34.62 | +67.33% | -165.99% |
| Sep 23, 2026 | $0.05 | -98.30% | $34.79 | +68.15% | -166.45% |
| Sep 22, 2026 | $0.04 | -98.31% | $34.88 | +68.58% | -166.89% |
| Sep 21, 2026 | $0.06 | -97.67% | $34.77 | +68.05% | -165.72% |
| Sep 18, 2026 | $0.06 | -97.80% | $35.47 | +71.44% | -169.24% |
| Sep 17, 2026 | $0.08 | -97.16% | $35.53 | +71.73% | -168.89% |
| Sep 16, 2026 | $0.07 | -97.47% | $36.37 | +75.79% | -173.26% |
| Sep 15, 2026 | $0.04 | -98.31% | $35.62 | +72.16% | -170.47% |
| Sep 14, 2026 | $0.05 | -98.29% | $35.81 | +73.08% | -171.37% |
| Sep 11, 2026 | $0.05 | -98.07% | $34.95 | +68.92% | -166.99% |
Page 1 of 17